Celldex Therapeutics, Inc. · NASDAQ:CLDX
Celldex Therapeutics, Inc. shareholders
As of Jun 30, 2026, 244 institutions reported holding Celldex Therapeutics, Inc. Largest: Wellington, BlackRock and Kynam Capital Management, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Celldex Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Wellington | 9.54M | +983K | Aug 14, 2026 | |
| BlackRock | 7M | +1.63M | Aug 7, 2026 | |
| Kynam Capital Management, LP | 5.32M | −518K | Aug 14, 2026 | |
| Vanguard | 4.98M | +883K | Aug 13, 2026 | |
| T. Rowe Price | 4.69M | +2.6M | Aug 14, 2026 | |
| State Street | 3.9M | +1.1M | Aug 7, 2026 | |
| Fidelity | 3.72M | −26,160 | Aug 13, 2026 | |
| Deep Track Capital, LP | 2.94M | +1.66M | Aug 14, 2026 | |
| Logos Global Management LP | 2.1M | +1.65M | Aug 14, 2026 | |
| Geode Capital | 2.02M | +334K | Aug 12, 2026 |